Kolexia
Bouguen Guillaume Gastro-entérologie
Bouguen Guillaume
Gastro-entérologie
Hôpital Pontchaillou
Rennes, France
263 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Rectocolite hémorragique Colite Fistule rectale Nécrose Incontinence anale Fistule Dysraphie spinale

Collaborateurs

Voir plus
Siproudhis Laurent
Siproudhis Laurent
Hôpital Pontchaillou, Rennes, France
Peyrin-Biroulet Laurent
Peyrin-Biroulet Laurent
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Laharie David
Laharie David
Hôpital Haut-lévêque, Pessac, France
Fumery Mathurin
Fumery Mathurin
Centre Hospitalier D'Amiens Salouël Site Sud, Salouël, France

Industries

Voir plus
Abbvie
43 collaboration(s)
Dernière en 2023
Janssen
30 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
26 collaboration(s)
Dernière en 2023
Sandoz
12 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
LUCENT-URGE: A Multicenter, Phase 3b, Open-Label, Single-Arm Study to Investigate Bowel Urgency and Its Relationship With Other Outcome Measures in Adults With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab
Essai Clinique (Lilly)   07 mars 2024
USTAP: USTekinumab in Fistulising Perianal Crohn's Disease (CD): The USTAP CD Study
Essai Clinique (Janssen)   18 janvier 2024
TRENCH 1: TRansmural hEaliNg Definition in CroHn's Disease - The TRENCH1 Study
Essai Clinique (Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives)   15 janvier 2024
ABTECT - Maintenance: A Randomized, Double-blind, Multicenter Phase III Study to Evaluate the Long-term Efficacy and Safety of ABX464 25 mg or 50 mg Once Daily as a Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Essai Clinique (Abivax S.A.)   15 décembre 2023
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis
Essai Clinique (Abivax S.A.)   15 décembre 2023
BIOÏDES: Intestinal Organoids
Essai Clinique (CHU Rennes)   24 novembre 2023
EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis : A Double Blinded Randomized Clinical Trial
Essai Clinique (CHU Rennes)   20 novembre 2023
Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID.
Journal of Crohn's & colitis   20 octobre 2023
Allogenic stem cells for Crohn's anal fistulas: Treating early improves the deep remission rate.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland   17 octobre 2023
Tofacitinib for patients with anti-TNF refractory ulcerative proctitis: a multicenter cohort study from the GETAID.
Journal of Crohn's & colitis   05 octobre 2023